Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma.

Literature DB >> 31852768

Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma.

Zhichao Feng¹, Pengfei Rong², Wei Wang¹.

Abstract

Entities: Disease Gene

Keywords: hepatocellular carcinoma; immunotherapy; meta-analysis

Mesh：

Substances：

Year: 2019 PMID： 31852768 DOI： 10.1136/gutjnl-2019-320116

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. p53 m⁶A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.

Authors: Weiwei Ke; Linlin Zhang; Xiangxuan Zhao; Zaiming Lu
Journal: Apoptosis Date: 2022-05-03 Impact factor: 4.677

2. Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.

Authors: Yawen Jiang; Dan Cai; Si Shi
Journal: Clin Epidemiol Date: 2022-04-29 Impact factor: 5.814

Review 3. Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?

Authors: D-W Sun; L An; H-Y Huang; X-D Sun; G-Y Lv
Journal: Clin Transl Oncol Date: 2020-05-27 Impact factor: 3.405

Review 4. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Authors: Li-Wei Qiu; Yi-Fei Liu; Xiao-Qing Cao; Yan Wang; Xiao-Hong Cui; Xian Ye; Shuo-Wen Huang; Hong-Jun Xie; Hai-Jian Zhang
Journal: World J Gastroenterol Date: 2020-05-14 Impact factor: 5.742

Review 5. Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects.

Authors: Misgana Negassi; Rodrigo Suarez-Ibarrola; Simon Hein; Arkadiusz Miernik; Alexander Reiterer
Journal: World J Urol Date: 2020-01-10 Impact factor: 4.226

10. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma.

Authors: Gao Li; Xiaowei Du; Xiaoxiong Wu; Shen Wu; Yufei Zhang; Jing Xu; Hao Wang; Tingsong Chen
Journal: Front Pharmacol Date: 2021-07-16 Impact factor: 5.810

Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma.

1. p53 m⁶A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.

2. Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.

Review 3. Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?

Review 4. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Review 5. Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects.

Review 6. Emerging roles of RNA methylation in gastrointestinal cancers.

7. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.

8. Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining.

9. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.

10. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma.

Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma.

1. p53 m6A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.

2. Indirect Comparisons via Sorafenib for the Comparative Effectiveness of Two PD-1/PD-L1 Inhibitors to Treat Advanced Hepatocellular Carcinoma Patients without Prior Systemic Therapies.

Review 3. Establishing peripheral PD-L1 as a prognostic marker in hepatocellular carcinoma patients: how long will it come true?

Review 4. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment.

Review 5. Application of artificial neural networks for automated analysis of cystoscopic images: a review of the current status and future prospects.

Review 6. Emerging roles of RNA methylation in gastrointestinal cancers.

7. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.

8. Correlation analysis of tumor mutation burden of hepatocellular carcinoma based on data mining.

9. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.

10. Large-Scale Transcriptome Analysis Identified a Novel Cancer Driver Genes Signature for Predicting the Prognostic of Patients With Hepatocellular Carcinoma.

1. p53 m⁶A modulation sensitizes hepatocellular carcinoma to apatinib through apoptosis.